No profile data available.
Coral Laboratories Limited (CORALAB.BO) is a healthcare company in the drug manufacturing contractors industry, based in Mumbai, India, with about 149 full-time employees.
It reported revenue of 1.13 billion INR for fiscal year 2025, up 37.9% from fiscal year 2024, and net income of 241.56 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 215.64 million INR, down 6.2% from a year before. Its market capitalization was 2.04 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Coral Laboratories Limited manufactures and sells pharmaceutical formulations in India, Ethiopia, and internationally.
Coral Laboratories reported 1.13 billion INR in revenue for fiscal year 2025, up 37.9% from 820.99 million INR in fiscal year 2024. In Q3 2026 revenue was 215.64 million INR.
2.04 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Everest Organics Limited (EVERESTO.BO), Gennex Laboratories Limited (GENNEX.BO), Brooks Laboratories Limited (BROOKS.NS), Syschem (India) Limited (SYSCHEM.BO).